Pharmaceuticals in the freshwater invertebrate, Gammarus pulex, determined using pulverised liquid extraction, solid phase extraction and liquid chromatography-tandem mass spectrometry

Science of the Total Environment

Volumn 511, Issue , 2015, Pages 153-160

  Miller, Thomas H ^a   McEneff, Gillian L ^a   Brown, Rebecca J ^b,c   Owen, Stewart F ^b   Bury, Nicolas R ^a   Barron, Leon P ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b ASTRAZENECA   (United Kingdom)

^c WCA ENVIRONMENT LTD   (United Kingdom)

Author keywords

Emerging contaminants; Environmental analysis; Gammarus pulex; Occurrence

Indexed keywords

AQUATIC ORGANISMS; DRUG PRODUCTS; EFFLUENT TREATMENT; LIQUID CHROMATOGRAPHY; LIQUIDS; MASS SPECTROMETRY; PHASE SEPARATION; WATER;

EMERGING CONTAMINANT; ENVIRONMENTAL ANALYSIS; FRESHWATER INVERTEBRATES; GAMMARUS PULEX; LIQUID CHROMATOGRAPHY TANDEM MASS SPECTROMETRY (LC MS/MS); LIQUID CHROMATOGRAPHY-TANDEM MASS SPECTROMETRY; OCCURRENCE; RELATIVE STANDARD DEVIATIONS;

EXTRACTION;

CARBAMAZEPINE; DIAZEPAM; NIMESULIDE; RIVER WATER; SURFACE WATER; TEMAZEPAM; TRIMETHOPRIM; WARFARIN; DRUG; FRESH WATER; WATER POLLUTANT;

AMPHIPOD; DRUG; EXTRACTION METHOD; INVERTEBRATE; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY;

AQUATIC ENVIRONMENT; ARTICLE; CONCENTRATION (PARAMETERS); DRY WEIGHT; EXTRACTION AND EXTRACTS; GAMMARUS PULEX; LIMIT OF DETECTION; LIMIT OF QUANTITATION; LIQUID CHROMATOGRAPHY; MEASUREMENT PRECISION; NONHUMAN; PROCESS OPTIMIZATION; PULVERIZED LIQUID EXTRACTION; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; SOLID PHASE EXTRACTION; TANDEM MASS SPECTROMETRY; UNITED KINGDOM; WATER CONTAMINATION; AMPHIPODA; ANALYSIS; ANIMAL; CHEMISTRY; ENVIRONMENTAL MONITORING; PROCEDURES; WATER POLLUTANT;

ENGLAND; THAMES RIVER [ENGLAND]; UNITED KINGDOM;

GAMMARUS PULEX; INVERTEBRATA;

AMPHIPODA; ANIMALS; CHROMATOGRAPHY, LIQUID; ENVIRONMENTAL MONITORING; FRESH WATER; PHARMACEUTICAL PREPARATIONS; SOLID PHASE EXTRACTION; TANDEM MASS SPECTROMETRY; WATER POLLUTANTS, CHEMICAL;

EID: 84919723357     PISSN: 00489697     EISSN: 18791026     Source Type: Journal    
DOI: 10.1016/j.scitotenv.2014.12.034     Document Type: Article

References (54)

1. Arnold K.E., Brown A.R., Ankley G.T., Sumpter J.P. Medicating the environment: assessing risks of pharmaceuticals to wildlife and ecosystems. Philos. Trans. R. Soc. B Biol. Sci. 2014, 369.
2. Ashauer R., Hintermeister A., O'Connor I., Elumelu M., Hollender J., Escher B.I. Significance of xenobiotic metabolism for bioaccumulation kinetics of organic chemicals in Gammarus pulex. Environ. Sci. Technol. 2012, 46:3498-3508.
3. Ashton D., Hilton M., Thomas K.V. Investigating the environmental transport of human pharmaceuticals to streams in the United Kingdom. Sci. Total Environ. 2004, 333:167-184.
4. Baker D.R., Kasprzyk-Hordern B. Multi-residue analysis of drugs of abuse in wastewater and surface water by solid-phase extraction and liquid chromatography-positive electrospray ionisation tandem mass spectrometry. J. Chromatogr. A 2011, 1218:1620-1631.
5. Baker D.R., Kasprzyk-Hordern B. Multi-residue determination of the sorption of illicit drugs and pharmaceuticals to wastewater suspended particulate matter using pressurised liquid extraction, solid phase extraction and liquid chromatography coupled with tandem mass spectrometry. J. Chromatogr. A 2011, 1218:7901-7913.
6. Barron L., Tobin J., Paull B. Multi-residue determination of pharmaceuticals in sludge and sludge enriched soils using pressurized liquid extraction, solid phase extraction and liquid chromatography with tandem mass spectrometry. J. Environ. Monit. 2008, 10:353-361.
7. Barron L., Havel J., Purcell M., Szpak M., Kelleher B., Paull B. Predicting sorption of pharmaceuticals and personal care products onto soil and digested sludge using artificial neural networks. Analyst 2009, 134:663-670.
8. Behera S.K., Kim H.W., Oh J.E., Park H.S. Occurrence and removal of antibiotics, hormones and several other pharmaceuticals in wastewater treatment plants of the largest industrial city of Korea. Sci. Total Environ. 2011, 409:4351-4360.
9. Brooks B.W. Fish on Prozac (and Zoloft): ten years later. Aquat. Toxicol. 2014, 151:61-67.
10. Brown K.D., Kulis J., Thomson B., Chapman T.H., Mawhinney D.B. Occurrence of antibiotics in hospital, residential, and dairy effluent, municipal wastewater, and the Rio Grande in New Mexico. Sci. Total Environ. 2006, 366:772-783.
11. Buerge I.J., Poiger T., Müller M.D., Buser H.-R. Combined sewer overflows to surface waters detected by the anthropogenic marker caffeine. Environ. Sci. Technol. 2006, 40:4096-4102.
12. Carmona E., Andreu V., Pico Y. Occurrence of acidic pharmaceuticals and personal care products in Tuna River Basin: from waste to drinking water. Sci. Total Environ. 2014, 484:53-63.
13. Commission E Commission Proposal on Priority Substances (COM(2011)876) 2012, 2014.
14. Corcoran J., Winter M.J., Tyler C.R. Pharmaceuticals in the aquatic environment: a critical review of the evidence for health effects in fish. Crit. Rev. Toxicol. 2010, 40:287-304.
15. Cueva-Mestanza R., Torres-Padrón M., Sosa-Ferrera Z., Santana-Rodríguez J. Microwave-assisted micellar extraction coupled with solid-phase extraction for preconcentration of pharmaceuticals in molluscs prior to determination by HPLC. Biomed. Chromatogr. 2008, 22:1115-1122.
16. De Lange H.J., Noordoven W., Murk A.J., Lürling M., Peeters E.T.H.M. Behavioural responses of Gammarus pulex (Crustacea, Amphipoda) to low concentrations of pharmaceuticals. Aquat. Toxicol. 2006, 78:209-216.
17. De Lange H.J., Peeters E.T.H.M., Lürling M. Changes in ventilation and locomotion of Gammarus pulex (Crustacea, Amphipoda) in response to low concentrations of pharmaceuticals. Human and Ecological Risk Assessment 2009, 15(1):111-120.
18. Dobson P.D., Kell D.B. Carrier-mediated cellular uptake of pharmaceutical drugs: an exception or the rule?. Nat. Rev. Drug Discov. 2008, 7:205-220.
19. Dodder N.G., Maruya K.A., Lee Ferguson P., Grace R., Klosterhaus S., La Guardia M.J., et al. Occurrence of contaminants of emerging concern in mussels (Mytilus spp.) along the California coast and the influence of land use, storm water discharge, and treated wastewater effluent. Mar. Pollut. Bull. 2014, 81:340-346.
20. Dussault È.B., Balakrishnan V.K., Solomon K.R., Sibley P.K. Matrix effects on mass spectrometric determinations of four pharmaceuticals and personal care products in water, sediments, and biota. Can. J. Chem. 2009, 87:662-672.
21. Ehmann P. Beverley Brook Information Pack 2014 2013, Environment Agency.
22. Feitosa-Felizzola J., Chiron S. Occurrence and distribution of selected antibiotics in a small Mediterranean stream (Arc River, Southern France). J. Hydrol. 2009, 364:50-57.
23. Friberg N., Andersen T.H., Hansen H.O., Iversen T.M., Jacobsen D., Krøjgaard L., et al. The effect of brown trout (Salmo Trutta L.) on stream invertebrate drift, with special reference to Gammarus pulex L. Hydrobiologia 1994, 294:105-110.
24. Gatidou G., Vassalou E., Thomaidis N.S. Bioconcentration of selected endocrine disrupting compounds in the Mediterranean mussel, Mytilus galloprovincialis. Mar. Pollut. Bull. 2010, 60:2111-2116.
25. Gomez M.J., Petrovic M., Fernandez-Alba A.R., Barcelo D. Determination of pharmaceuticals of various therapeutic classes by solid-phase extraction and liquid chromatography-tandem mass spectrometry analysis in hospital effluent wastewaters. J. Chromatogr. A 2006, 1114:224-233.
26. Gorman A. Water Body Action Plan 2014 2013, Environment Agency.
27. Hamelink J.L., Spacie A. Fish and chemicals: the process of accumulation. Annu. Rev. Pharmacol. Toxicol. 1977, 17:167-177.
28. Huerta B., Rodriguez-Mozaz S., Barcelo D. Pharmaceuticals in biota in the aquatic environment: analytical methods and environmental implications. Anal. Bioanal. Chem. 2012, 404:2611-2624.
29. Huerta B., Jakimska A., Gros M., Rodriguez-Mozaz S., Barcelo D. Analysis of multi-class pharmaceuticals in fish tissues by ultra-high-performance liquid chromatography tandem mass spectrometry. J. Chromatogr. A 2013, 1288:63-72.
30. Johnson E.A., An G.-H. Astaxanthin from microbial sources. Crit. Rev. Biotechnol. 1991, 11:297-326.
31. Klosterhaus S.L., Grace R., Hamilton M.C., Yee D. Method validation and reconnaissance of pharmaceuticals, personal care products, and alkylphenols in surface waters, sediments, and mussels in an urban estuary. Environ. Int. 2013, 54:92-99.
32. Kok S.J., Debets A.J.J. Fast sample preparation for analysis of tablets and capsules: the ball-mill extraction method. J. Pharm. Biomed. Anal. 2001, 26:599-604.
33. Kosma C.I., Lambropoulou D.A., Albanis T.A. Occurrence and removal of PPCPs in municipal and hospital wastewaters in Greece. J. Hazard. Mater. 2010, 179:804-817.
34. Kwon J.-W., Armbrust K.L., Vidal-Dorsch D., Bay S.M., Xia K. Determination of 17 alpha-ethynylestradiol, carbamazepine, diazepam, simvastatin, and oxybenzone in fish livers. J. AOAC Int. 2009, 92:359-369.
35. Lacey C., McMahon G., Bones J., Barron L., Morrissey A., Tobin J.M. An LC-MS method for the determination of pharmaceutical compounds in wastewater treatment plant influent and effluent samples. Talanta 2008, 75:1089-1097.
36. Lacey C., Basha S., Morrissey A., Tobin J. Occurrence of pharmaceutical compounds in wastewater process streams in Dublin, Ireland. Environ. Monit. Assess. 2012, 184:1049-1062.
37. Maltby L., Clayton S.A., Wood R.M., McLoughlin N. Evaluation of the Gammarus pulex in situ feeding assay as a biomonitor of water quality: robustness, responsiveness, and relevance. Environ. Toxicol. Chem. 2002, 21:361-368.
38. McEneff G., Barron L., Kelleher B., Paull B., Quinn B. The determination of pharmaceutical residues in cooked and uncooked marine bivalves using pressurised liquid extraction, solid-phase extraction and liquid chromatography-tandem mass spectrometry. Anal. Bioanal. Chem. 2013, 405:9509-9521.
39. McEneff G., Barron L., Kelleher B., Paull B., Quinn B. A year-long study of the spatial occurrence and relative distribution of pharmaceutical residues in sewage effluent, receiving marine waters and marine bivalves. Sci. Total Environ. 2014, 476-477:317-326.
40. McKim J., Schmieder P., Veith G. Absorption dynamics of organic chemical transport across trout gills as related to octanol-water partition coefficient. Toxicol. Appl. Pharmacol. 1985, 77:1-10.
41. Meredith-Williams M., Carter L.J., Fussell R., Raffaelli D., Ashauer R., Boxall A.B.A. Uptake and depuration of pharmaceuticals in aquatic invertebrates. Environ. Pollut. 2012, 165:250-258.
42. MHRA Medicines and Healthcare Products Regulatory Agency 2014, 2014.
43. Nyman A.-M., Schirmer K., Ashauer R. Toxicokinetic-toxicodynamic modelling of survival of Gammarus pulex in multiple pulse exposures to propiconazole: model assumptions, calibration data requirements and predictive power. Ecotoxicology 2012, 21:1828-1840.
44. Rand-Weaver M., Margiotta-Casaluci L., Patel A., Panter G.H., Owen S.F., Sumpter J.P. The read-across hypothesis and environmental risk assessment of pharmaceuticals. Environ. Sci. Technol. 2013, 47:11384-11395.
45. Roberts P.H., Thomas K.V. The occurrence of selected pharmaceuticals in wastewater effluent and surface waters of the lower Tyne catchment. Sci. Total Environ. 2006, 356:143-153.
46. Schultz M.M., Furlong E.T., Kolpin D.W., Werner S.L., Schoenfuss H.L., Barber L.B., et al. Antidepressant pharmaceuticals in two U.S. effluent-impacted streams: occurrence and fate in water and sediment, and selective uptake in fish neural tissue. Environ. Sci. Technol. 2010, 44:1918-1925.
47. Silva B.F.d, Jelic A., López-Serna R., Mozeto A.A., Petrovic M., Barceló D. Occurrence and distribution of pharmaceuticals in surface water, suspended solids and sediments of the Ebro river basin, Spain. Chemosphere 2011, 85:1331-1339.
48. Subedi B., Du B., Chambliss C.K., Koschorreck J., Rudel H., Quack M., et al. Occurrence of pharmaceuticals and personal care products in German fish tissue: a national study. Environ. Sci. Technol. 2012, 46:9047-9054.
49. Sumpter J.P., Donnachie R.L., Johnson A.C. The apparently very variable potency of the anti-depressant fluoxetine. Aquat. Toxicol. 2014, 151:57-60.
50. Tanoue R., Nomiyama K., Nakamura H., Hayashi T., Kim J.-W., Isobe T., et al. Simultaneous determination of polar pharmaceuticals and personal care products in biological organs and tissues. J. Chromatogr. A 2014, 1355:193-205.
51. Thomas K.V., Hilton M.J. The occurrence of selected human pharmaceutical compounds in UK estuaries. Mar. Pollut. Bull. 2004, 49:436-444.
52. Vazquez-Roig P., Blasco C., Pico Y. Advances in the analysis of legal and illegal drugs in the aquatic environment. Trac-Trends Anal. Chem. 2013, 50:65-77.
53. Weigel S., Kallenborn R., Hühnerfuss H. Simultaneous solid-phase extraction of acidic, neutral and basic pharmaceuticals from aqueous samples at ambient (neutral) pH and their determination by gas chromatography-mass spectrometry. J. Chromatogr. A 2004, 1023:183-195.
54. Yoon Y., Ryu J., Oh J., Choi B.-G., Snyder S.A. Occurrence of endocrine disrupting compounds, pharmaceuticals, and personal care products in the Han River (Seoul, South Korea). Sci. Total Environ. 2010, 408:636-643.